Examining the prevalence of prediabetes in pediatrics (VIDEO)

The combination therapy yielded boosted treatment benefits of navepegritide, including improvement in mean ACH Z-score and mean annualized growth.

Contemporary Pediatrics sits down exclusively with Philippe F. Backeljauw, MD, a pediatric endocrinologist to discuss the one key condition for which he believes community pediatricians should be especially aware-Turner syndrome.

The decision makes hydrocortisone oral solution (Khindivi; Eton Pharmaceuticals) the only FDA-approved oral formulation of hydrocortisone.

Somapacitan was non-inferior and had a similar safety profile and clinical outcomes compared to once-daily somatropin in improving yearly growth rates.

Most want to start the conversation, but confidence and timing vary.

The FDA is warning diabetes patients that information from CGMs, insulin pumps, and automated dosing systems could fail to be delivered if smartphone settings are not properly configured.